TECHNICAL FIELD
The present invention relates to a molecular targeted antitumor drug, in particular to a form A of mesylate for nicotinamide derivatives, which is named Form A, and preparation method and application thereof.
BACKGROUND ART
Nicotinamide derivative (Aptinib), with a molecular formula